Stock listing

NASDAQ:ACER Acer Therapeutics Inc Stock

Follow Acer Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:ACER no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ACER
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Acer Therapeutics Inc on 6ix

Decks
58 decks · latest Jun 26, 2023

Decks

DeckKindSlidesDate
Investor Presentation (June 2023)Investor deck26 slidesJun 26, 2023
Investor Presentation (March 2023)Investor deck25 slidesMar 27, 2023
Investor Presentation (February 2023)Investor deck36 slidesFeb 1, 2023
Investor Presentation (January 2023)Investor deck36 slidesJan 5, 2023
Investor Presentation (January 2023)Investor deck33 slidesJan 3, 2023
Investor Presentation (August 2022)Investor deck37 slidesAug 23, 2022
Investor Presentation (June 2022)Investor deck34 slidesJun 29, 2022
Investor Presentation (May 2022)Investor deck33 slidesMay 16, 2022
Investor Presentation (March 2022)Investor deck33 slidesMar 16, 2022
Investor Presentation (October 2021)Investor deck46 slidesOct 14, 2021
Show 50 decks
DeckKindSlidesDate
Investor Presentation (August 2021)Investor deck46 slidesAug 10, 2021
Investor Presentation (June 2021)Investor deck47 slidesJun 17, 2021
Investor Presentation (May 2021)Investor deck47 slidesMay 17, 2021
Investor Presentation (April 2021)Investor deck46 slidesApr 2, 2021
Investor Presentation (March 2021)Investor deck46 slidesMar 1, 2021
Investor Presentation (January 2021)Investor deck45 slidesJan 15, 2021
Investor Presentation (November 2020)Investor deck49 slidesNov 10, 2020
Investor Presentation (September 2020)Investor deck47 slidesSep 1, 2020
Investor Presentation (August 2020)Investor deck47 slidesAug 13, 2020
Investor Presentation (July 2020)Investor deck47 slidesJul 14, 2020
Investor Presentation (May 2020)Investor deck44 slidesMay 11, 2020
Investor Presentation (March 2020)Investor deck35 slidesMar 18, 2020
Investor Presentation (February 2020)Investor deck40 slidesFeb 24, 2020
Investor Presentation (January 2020)Investor deck40 slidesJan 2, 2020
Investor Presentation (October 2019)Investor deck41 slidesOct 29, 2019
Investor Presentation (August 2019)Investor deck41 slidesAug 13, 2019
Corporate Update (August 2019)Corporate update51 slidesAug 5, 2019
Investor Presentation (April 2019)Investor deck35 slidesApr 5, 2019
Investor Presentation (January 2019)Investor deck35 slidesJan 7, 2019
Investor Presentation (June 2018)Investor deck28 slidesJun 29, 2018
Investor Presentation (December 2017)Investor deck29 slidesDec 11, 2017
Investor Presentation (September 2017)Investor deck25 slidesSep 26, 2017
Opexa Therapeutics — Investor Presentation (September 2016)Investor deck24 slidesSep 12, 2016
Opexa Therapeutics — Corporate Update (November 2015)Corporate update62 slidesNov 10, 2015
Opexa Therapeutics — Investor Presentation (September 2015)Investor deck27 slidesSep 2, 2015
Opexa Therapeutics — Investor Presentation (May 2015)Investor deck27 slidesMay 12, 2015
Opexa Therapeutics — IPO Roadshow (January 2015)IPO roadshow27 slidesJan 28, 2015
Opexa Therapeutics — Investor Presentation (October 2014)Investor deck37 slidesOct 9, 2014
Opexa Therapeutics — Investor Presentation (September 2014)Investor deck27 slidesSep 8, 2014
Opexa Therapeutics — Investor Presentation (August 2014)Investor deck38 slidesAug 14, 2014
Opexa Therapeutics — Q1 2014 Earnings PresentationEarnings7 slidesMay 14, 2014
Opexa Therapeutics — Investor Presentation (March 2014)Investor deck38 slidesMar 24, 2014
Opexa Therapeutics — Q4 2013 Earnings PresentationEarnings9 slidesFeb 28, 2014
Opexa Therapeutics — Q3 2013 Earnings PresentationEarnings7 slidesNov 7, 2013
Opexa Therapeutics — Rodman & Renshaw 15th Annual Global Investment Conference 2013Conference20 slidesSep 10, 2013
Opexa Therapeutics — Q2 2013 Earnings PresentationEarnings11 slidesAug 14, 2013
Opexa Therapeutics — IPO Roadshow (July 2013)IPO roadshow5 slidesJul 29, 2013
Opexa Therapeutics — IPO Roadshow (July 2013)IPO roadshow39 slidesJul 22, 2013
Opexa Therapeutics — Q1 2013 Earnings PresentationEarnings9 slidesMay 14, 2013
Opexa Therapeutics — Investor Presentation (February 2013)Investor deck20 slidesFeb 11, 2013

This page holds 50 of 58 decks. Open Decks

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Donald Joseph
Other companies: Achieve Life Sciences, Inc. (Director · Aug 1, 2017 – May 31, 2022 · Past); Humanigen Inc (Chief Legal Officer · Jul 30, 2013 – Feb 16, 2015 · Past); Renovis Inc (SVP, Gen. Counsel & Secretary · May 16, 2006 – Jan 3, 2007 · Past); Abgenix Inc (Senior VP, Gen. Counsel & Sec. · Apr 1, 2006 – Apr 1, 2006 · Past)
See Remarks · Apr 16, 2018 – Nov 17, 2023 · Past
Gail J Maderis
Other companies: Durect Corporation (Director · Since at least Jan 4, 2021); Allarity Therapeutics, Inc. (Director · Dec 20, 2021 – Dec 20, 2021 · Past); Stablecoin Development Corporation (Director · Oct 5, 2010 – May 30, 2019 · Past)
Director · Oct 27, 2011 – Sep 30, 2016 · Past
Jason Amello
Other companies: TScan Therapeutics, Inc. (Chief Financial Officer · Since at least Jan 29, 2024); Candel Therapeutics, Inc. (Chief Financial Officer · Sep 21, 2022 – Nov 28, 2023 · Past); Akebia Therapeutics, Inc. (SVP, CFO & Treasurer · Apr 11, 2019 – Feb 28, 2020 · Past)
Director · Jan 2, 2020 – Mar 14, 2023 · Past
Michael Richman
Other companies: NextCure, Inc. (President & CEO · Since at least May 8, 2019); GenVec Inc (Director · Nov 13, 2015 – Jun 16, 2017 · Past); Palvella Therapeutics, Inc. (Director · Jul 15, 2015 – Jun 21, 2023 · Past)
Director · Jun 30, 2015 – Sep 30, 2016 · Past
Adrian Quartel
Other companies: Spruce Biosciences, Inc. (Chief Medical Officer · Since at least Jul 27, 2026); Zevra Therapeutics, Inc. (Chief Medical Officer · Since at least Dec 6, 2024)
Chief Medical Officer · Feb 21, 2022 – Mar 14, 2023 · Past
John Michael Dunn
Other companies: Immunic, Inc. (General Counsel and Secretary · Nov 17, 2014 – Jan 11, 2019 · Past); Biogen Inc. (EVP, New Ventures · Dec 31, 2005 – Feb 24, 2009 · Past)
Director · Sep 19, 2017 – Nov 17, 2023 · Past
Michelle Griffin
Other companies: Adaptive Biotechnologies Corporation (Board Member · Since at least Mar 6, 2023); Aduro Biotech Inc (Director · May 26, 2022 – Aug 11, 2023 · Past)
Director · Mar 14, 2023 – Mar 14, 2023 · Past
Hubert Birner
Other companies: Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past)
Director · Dec 12, 2017 – Aug 1, 2018 · Past
Luc Marengere
Other companies: CoLucid Pharmaceuticals Inc (Director · May 5, 2015 – Mar 1, 2017 · Past)
Director · Sep 19, 2017 – Aug 1, 2018 · Past
Neil K. Warma
Other companies: ProMIS Neurosciences Inc. (President and Chief Executive Officer · Since at least Jul 7, 2022)
President, CEO and Acting CFO, Director · Jan 16, 2009 – May 16, 2016 · Past
All 22 people
PersonSeat
Steve Aselage
Other companies: BioCryst Pharmaceuticals, Inc. (Director · May 24, 2024 – Jun 12, 2024 · Past)
Director · Nov 17, 2023 – Nov 17, 2023 · Past
Tanya Hayden
Other companies: Zevra Therapeutics, Inc. (Senior Vice President, Chief of Staff · Since at least Nov 4, 2026)
Chief Operating Officer · Jun 19, 2022 – Mar 14, 2023 · Past
Bernard H PaulChief People Officer · Jan 14, 2022 – Mar 14, 2023 · Past
Chris SchellingPRESIDENT AND CEO, Director · Sep 19, 2017 – Nov 17, 2023 · Past
Donna R RillChief Development Officer · Mar 29, 2007 – May 16, 2016 · Past
Hans-Peter HartungDirector · Mar 19, 2014 – Mar 30, 2015 · Past
Harry S PalminCHIEF FINANCIAL OFFICER · Sep 19, 2017 – Nov 17, 2023 · Past
Jefferson E DavisCHIEF BUSINESS OFFICER · Mar 14, 2023 – Nov 17, 2023 · Past
Lynne HohlfeldCFO · Jun 30, 2006 – Jan 16, 2009 · Past
Robert D SteinerChief Medical Officer · Sep 19, 2017 – Sep 19, 2017 · Past
Salma Jutt-EghbaliChief Commercial Officer · Dec 3, 2018 – Dec 4, 2018 · Past
William RouseCFO · Jan 25, 2006 – Jun 15, 2006 · Past

Open People

Log in to ask 6ix AI your own questions about Acer Therapeutics Inc.